US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,769.60

+1.730.06%

Number of Gainers:3

Number of Losers:2

Number of Flat:- -

PE:- -

High:2,809.10

Open:2,767.88

Low:2,743.69

Close:2,767.87

Volume:9.68M

Turnover:169.08M

Market Cap:44.28B

Float Cap:41.35B

Loading ...

Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio

MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management

THOMSON REUTERS

MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed

THOMSON REUTERS

MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology

THOMSON REUTERS

MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study

THOMSON REUTERS

MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales

THOMSON REUTERS

MannKind Corporation - to Have Representation on Rose Pharma Board of Directors

THOMSON REUTERS

Teva initiated with an Outperform at Leerink

Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer

Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib

THOMSON REUTERS

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

THOMSON REUTERS

Teva Pharmaceuticals : UBS Raises Target Price to $48 from $42

THOMSON REUTERS

Teva Announces Launch of Offering of Senior Notes

THOMSON REUTERS

Femasys registers to sell 28.12M shares of common stock for holders

Femasys - Files for Resale of up to 28,124,997 Shares of Common Stock - SEC Filing

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data

Veru CEO Steiner to Join Cantor Global Healthcare Conference Fireside Chat

MannKind to Present at Upcoming Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2769.5986,"timestamp":1788983999999,"preClose":2767.868,"halted":0,"volume":9677389,"delay":0,"changeRate":0.000625,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.730713,"latestTime":"09-09 16:00:00 EDT","open":2767.8787,"high":2809.0952,"low":2743.6926,"amount":169077693.777757,"amplitude":0.023629,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789027200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.669682,"peRate":69.896269,"turnoverRate":0.006739,"increases":3,"decrements":2,"flats":0,"marketCap":44277196647,"floatMarketCap":41345877531},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2809.0952,"amplitude":0.023629,"preClose":2767.868,"low":2743.6926,"pbRate":"5.669682","latestPrice":2769.5986,"volume":9677389,"delay":0,"open":2767.8787,"prevYearClose":2379.9924,"prevWeekClose":2734.7136,"prevMonthClose":2714.4358,"prevQuarterClose":2562.5076,"fiveDayClose":2723.1304,"twentyDayClose":2741.0657,"sixtyDayClose":2604.7175,"secType":"PLATE","market":"US","turnoverRate":0.006739,"peRate":69.896269,"marketCap":44277196647,"floatMarketCap":41345877531,"timestamp":1788983999999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":3,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666535312","title":"Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535312","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535312?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:04","pubTimestamp":1788959042,"startTime":"0","endTime":"0","summary":"Femasys partners with CapexMD to offer financing for FemaSeed fertility portfolioFemasys partnered with CapexMD to offer dedicated patient financing for its FemaSeed-led fertility portfolio.Financing ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLc5TGtl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","LU2210149790.SGD","BK4082","IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014021.USD","IE00BN0W2W23.USD","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","NDAQ","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","FEMY","BK4584","BCDF","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4588","IE00BQXX3F31.USD","BK4539","SG9999014013.SGD","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584094","title":"MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584094","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584094?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949853,"startTime":"0","endTime":"0","summary":"MannKind partners with Rose Pharma on inhaled rapid-acting GLP-1 weight-loss therapyMannKind entered a worldwide licensing and collaboration agreement with Rose Pharma to develop ROSE-010 Technosphere","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6Q2z0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BQXX3D17.EUR","BK4585","IE00BQXX3F31.USD","SG9999014005.SGD","BK4112","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","BK4584","BK4139","LU0314104364.USD","BK4588","MNKD","SG9999014013.SGD","NDAQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BCDF","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858406","title":"MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858406?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666840665","title":"MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2666840665","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666840665?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584063","title":"MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584063?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4584","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584062","title":"MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584062","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584062?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258405","title":"MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258405","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258405?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666061584","title":"MannKind Corporation - to Have Representation on Rose Pharma Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666061584","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666061584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584165","title":"Teva initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584165?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948675,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Teva (TEVA) with an Outperform rating and $45 price target Published first on TheFly – the ultimate source for real-t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2324357040.USD","BK4566","LU1983299246.USD","BK4596","TEVA","BK4007","BK4557","BK4588","BK4559","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320219","title":"Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320219","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320219?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869844,"startTime":"0","endTime":"0","summary":"Veru plans Phase 2 trial of oral sabizabulin in daraxonrasib-resistant metastatic pancreatic cancerVeru will advance oral sabizabulin into a planned Phase 2 trial for metastatic KRAS-driven pancreatic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLlxV4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4183","BK4588","BK4007","LU2095319765.USD","BK4584","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","VERU","SG9999014021.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","LU0314104364.USD","IE00BQXX3F31.USD","SG9999014039.USD","BK4557","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665296320","title":"Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2665296320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665296320?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4557","VERU","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665202933","title":"Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665202933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665202933?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4183","VERU","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665039080","title":"Teva Pharmaceuticals : UBS Raises Target Price to $48 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2665039080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665039080?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:01","pubTimestamp":1788768098,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nAZN4TIONZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4596","BK4584","BK4007","LU2324357040.USD","BK4588","BK4557","LU1983299246.USD","BK4585","BK4566","TEVA","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397717","title":"Teva Announces Launch of Offering of Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397717?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:53","pubTimestamp":1788767586,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUA6GXFN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","TEVA","BK4584","BK4585","BK4007","BK4596","BK4559","BK4557","LU2324357040.USD","BK4588","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664041728","title":"Femasys registers to sell 28.12M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2664041728","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664041728?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:10","pubTimestamp":1788469816,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 28.12M shares of common stock. The company is not ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-registers-to-sell-28-12m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-registers-to-sell-28-12m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4082","BK4584","FEMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804981","title":"Femasys - Files for Resale of up to 28,124,997 Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804981?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:07","pubTimestamp":1788469664,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V18N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4584","BK4539","FEMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","BK4588","IE00BJJMRZ35.SGD","BK4585","BK4596","BK4584","BK4581","BK4559","LU1983299246.USD","BBH","LU2324357040.USD","XLV","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0128526141.USD","BK4557","LABU","BK4137","TEVA","IDNA","LU0029874061.USD","LU0320765992.SGD","PTH","IE00B2B36J28.USD","BK4139","LU0109394709.USD","BK4007","CANC","IE0002141913.USD","HCSG","RVMD","IE0009354923.USD","LU0889565916.HKD","IE0009355771.USD","XBI","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884383","title":"Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884383","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664884383?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:15","pubTimestamp":1788365724,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Umer Raffat has maintained their bullish stance on TEVA stock, giving a Buy rating on August 31. Umer Raffat has given his Buy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/teva-upgraded-to-buy-on-strengthening-autoimmune-pipeline-and-validating-celiac-disease-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/teva-upgraded-to-buy-on-strengthening-autoimmune-pipeline-and-validating-celiac-disease-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1983299246.USD","LU2324357040.USD","BK4566","BK4557","TEVA","BK4596","BK4559","BK4585","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811447","title":"Veru CEO Steiner to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811447","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811447?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352326,"startTime":"0","endTime":"0","summary":"Veru CEO Steiner to join Cantor Global Healthcare Conference fireside chatVeru will join the 2026 Cantor Global Healthcare Conference in New York on Sept. 9, 2026.CEO Mitchell Steiner is scheduled for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5hC4BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014005.SGD","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","BK4557","IE00B64PRP62.GBP","IE00BQXX3D17.EUR","BK4585","BK4112","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014039.USD","BK4183","IE00BQXX3C00.GBP","IE00BKPKM429.USD","BCDF","SG9999014021.USD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014013.SGD","BK4007","BK4584","IE00BQXX3F31.USD","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581122","title":"MannKind to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581122","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581122?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"Investor Relations. Kate Miranda. ir@mnkd.com. Media Relations. Christie Iacangelo. media@mnkd.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355137/29517/en/mannkind-to-present-at-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4584","MNKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}